Helix Biopharm (HBP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
| 07-2015 | 07-2014 | 07-2013 | 07-2012 | 07-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,792 | 6,980 | 4,493 | 4,862 | 19,044 |
| Receivables | 491 | 343 | 559 | 733 | 1,906 |
| Inventories | N/A | N/A | 0 | 421 | 528 |
| TOTAL | $7,467 | $7,405 | $5,191 | $6,123 | $21,680 |
| Non-Current Assets | |||||
| PPE Net | 329 | 448 | 677 | 1,049 | 2,031 |
| Other Non-Current Assets | 0 | 0 | 0 | 444 | 660 |
| TOTAL | $329 | $448 | $677 | $1,493 | $2,691 |
| Total Assets | $7,796 | $7,853 | $5,868 | $7,616 | $24,371 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 262 | 566 | 304 | 650 | 1,085 |
| Accrued Expenses | 707 | 476 | 621 | 694 | 804 |
| TOTAL | $969 | $1,042 | $948 | $1,369 | $2,210 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 23 | 48 |
| TOTAL | $0 | $0 | $0 | $23 | $48 |
| Total Liabilities | $969 | $1,042 | $948 | $1,392 | $2,258 |
| Shareholders' Equity | |||||
| Common Shares | 112,288 | 107,079 | 101,407 | 0 | 0 |
| Retained earnings | -135,656 | -126,926 | -118,244 | -116,699 | -98,611 |
| Other shareholders' equity | 11,740 | 16,693 | 12,785 | 13,203 | 11,557 |
| TOTAL | $6,827 | $6,811 | $4,920 | $6,224 | $22,113 |
| Total Liabilities And Equity | $7,796 | $7,853 | $5,868 | $7,616 | $24,371 |